INTERNATIONAL PATENT: UNIVERSITY OF ROCHESTER FILES APPLICATION FOR "RNA-EDITING GENE THERAPY APPROACHES FOR TREATING MYOTONIC DYSTROPHY TYPE 1 (DM1)"

GENEVA, April 8 -- UNIVERSITY OF ROCHESTER (601 Elmwood Avenue, Box URVRochester, NY 14642) filed a patent application (PCT/US2024/048775) for "RNA-EDITING GENE THERAPY APPROACHES FOR TREATING MYOTONIC DYSTROPHY TYPE 1 (DM1)" on Sep 27, 2024. With publication no. WO/2025/072604, the details related to the patent application was published on Apr 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ANDERSON, Douglas, Matthew (23 Lodge Pole RoadPittsford, NY 14534)

Abstract: The present invention provides proteins, nucleic acids, systems and methods for treating Myotonic Dystrophy Type 1 (DM1...